Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Röllig C, Serve H, Hüttmann A. et al. Study Alliance Leukaemia.
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.

Lancet Oncol 2015;
16 (16) 1691-1699

Bibliographische Angaben herunterladen

Aufrufen in: